Clinic
Greater Toledo Urgent Cares, LLC.
Greater Toledo Urgent Cares, LLC. was paid $10.91M by Medicaid between Jan 2018 and Dec 2024, across 35 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 59% of everything it billed.
33Billing provider infoGREATER TOLEDO URGENT CARES, LLC.
TOLEDO, OH 43623
TOLEDO, OH 43623
33aNPI1982993010assigned 03/29/2011
33bProvider typeUrgent Care Clinic/Center
28Total paid$10.91M
24GClaims283,226
24DCodes billed35
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Ohio
Rank by total paid#5 of 95
Median peer was paid$201K
This provider vs. median54×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,366 | $1.20M | |
| 2019 | 35,255 | $1.37M | |
| 2020 | 27,663 | $1.14M | |
| 2021 | 38,741 | $1.73M | |
| 2022 | 43,810 | $1.72M | |
| 2023 | 58,275 | $2.06M | |
| 2024incomplete | 50,116 | $1.69M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 59% | 110,818 | 101,085 | $6.42M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 21% | 30,854 | 29,012 | $2.30M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 5.7% | 18,153 | 16,599 | $625K |
| 99051 | 2.7% | 23,144 | 21,267 | $297K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.6% | 3,551 | 3,404 | $280K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 21,262 | 19,670 | $227K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 21,919 | 12,360 | $224K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 6,008 | 5,716 | $156K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.3% | 3,575 | 3,404 | $141K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 1,323 | 1,288 | $67K |
| 81025 | <1% | 9,101 | 8,445 | $51K | |
| 81002 | <1% | 14,644 | 13,549 | $28K |
23 more codes
| 99205 | Prolong outpt/office vis | <1% | 277 | $27K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 724 | $14K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,215 | $12K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,075 | $7K |
| 87807 | <1% | 816 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,562 | $7K |
| 73130 | <1% | 190 | $3K | |
| 73630 | <1% | 161 | $3K | |
| 87808 | <1% | 259 | $3K | |
| 73610 | <1% | 116 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,865 | $2K |
| 99406 | <1% | 330 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 518 | $1K |
| 29125 | <1% | 12 | $280.29 | |
| 73110 | <1% | 14 | $243.36 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 790 | $180.36 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 74 | $152.49 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 93 | $128.90 |
| 82948 | <1% | 29 | $90.72 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 383 | $45.15 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 106 | $10.94 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 19 | $10.83 |
| 99072 | <1% | 246 | $1.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAHMOUD, WALID (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Gtuc-Michigan PC | Temperance, MI | $344K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.